{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:17:24Z","timestamp":1793427444435,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403860"],"award-info":[{"award-number":["82403860"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.mtbio.2026.102924","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:38:10Z","timestamp":1770770290000},"page":"102924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Galangin-loaded biomimetic dendritic cells membrane nanovaccine reprograms the ovarian cancer microenvironment via Stat3\/IDO1\/AhR axis to boost immunotherapy"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9028-1658","authenticated-orcid":false,"given":"Nuerbiye","family":"Aobulikasimu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lele","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidiresi","family":"Maimaitiyiming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilimureti","family":"Kasimu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adila","family":"Aipire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxiong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3295-6096","authenticated-orcid":false,"given":"Jinyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mtbio.2026.102924_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44246-9","article-title":"Advanced stage, high-grade primary tumor ovarian cancer: a multi-omics dissection and biomarker prediction process","volume":"13","author":"Honar","year":"2023","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.mtbio.2026.102924_bib2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41571-024-00937-4","article-title":"Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach","volume":"21","author":"Ghisoni","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.mtbio.2026.102924_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10330-022-0582-2","article-title":"Differential centrifugation enhances the anti-tumor immune effect of tumor lysate-pulsed dendritic cell vaccine against glioblastoma","volume":"8","author":"Liu","year":"2022","journal-title":"Oncol Translation Med"},{"key":"10.1016\/j.mtbio.2026.102924_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101848","article-title":"Antigen cross-presentation by dendritic cells: a critical axis in cancer immunotherapy","volume":"71","author":"Moussion","year":"2024","journal-title":"Semin. Immunol."},{"issue":"8","key":"10.1016\/j.mtbio.2026.102924_bib5","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1021\/acsnano.3c11189","article-title":"Antigen self-presented personalized nanovaccines boost the immunotherapy of highly invasive and metastatic tumors","volume":"18","author":"Wang","year":"2024","journal-title":"ACS Nano"},{"issue":"14","key":"10.1016\/j.mtbio.2026.102924_bib6","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.3390\/ijms25147509","article-title":"Enhancing dendritic cell cancer vaccination: the synergy of immune checkpoint inhibitors in combined therapies","volume":"25","author":"Zanotta","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.mtbio.2026.102924_bib7","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1038\/s41467-023-42155-z","article-title":"Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mtbio.2026.102924_bib8","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1038\/s41467-025-59977-8","article-title":"Neoantigen enriched biomimetic nanovaccine for personalized cancer immunotherapy","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"issue":"47","key":"10.1016\/j.mtbio.2026.102924_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202205950","article-title":"Direct presentation of tumor\u2010associated antigens to induce adaptive immunity by personalized dendritic cell\u2010mimicking nanovaccines","volume":"34","author":"Zhang","year":"2022","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.mtbio.2026.102924_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/ot9.0000000000000014","article-title":"Development of therapeutic cancer vaccines using nanomicellar preparations","volume":"9","author":"Qin","year":"2023","journal-title":"Oncol Translation Med"},{"issue":"7","key":"10.1016\/j.mtbio.2026.102924_bib11","article-title":"Artificial mini dendritic cells boost T cell-based immunotherapy for ovarian cancer","volume":"7","author":"Cheng","year":"2020","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.mtbio.2026.102924_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111548","article-title":"The role of dendritic cells in cancer immunity and therapeutic strategies","volume":"128","author":"Tai","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"50","key":"10.1016\/j.mtbio.2026.102924_bib13","doi-asserted-by":"crossref","first-page":"34063","DOI":"10.1021\/acsnano.4c09653","article-title":"Biomimetic dendritic cell-based nanovaccines for reprogramming the immune microenvironment to boost tumor immunotherapy","volume":"18","author":"Wang","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.mtbio.2026.102924_bib14","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200264","article-title":"Tumor-infiltrating dendritic cell states are conserved across solid human cancers","volume":"218","author":"Gerhard","year":"2021","journal-title":"J. Exp. Med."},{"issue":"8071","key":"10.1016\/j.mtbio.2026.102924_bib15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41586-025-09000-3","article-title":"STAT5 and STAT3 balance shapes dendritic cell function and tumour immunity","volume":"643","author":"Zhou","year":"2025","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mtbio.2026.102924_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12964-025-02101-6","article-title":"Cooperative Hedgehog\/GLI and JAK\/STAT signaling drives immunosuppressive tryptophan\/kynurenine metabolism via synergistic induction of IDO1 in skin cancer","volume":"23","author":"Elmer","year":"2025","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.mtbio.2026.102924_bib17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13045-018-0644-y","article-title":"Targeting the IDO1 pathway in cancer: from bench to bedside","volume":"11","author":"Liu","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.102924_bib18","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1038\/s41467-022-31126-5","article-title":"Adipocyte-derived kynurenine promotes obesity and insulin resistance by activating the AhR\/STAT3\/IL-6 signaling","volume":"13","author":"Huang","year":"2022","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.mtbio.2026.102924_bib19","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tips.2023.04.006","article-title":"Modulation of T cells by tryptophan metabolites in the kynurenine pathway","volume":"44","author":"Stone","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"35","key":"10.1016\/j.mtbio.2026.102924_bib20","doi-asserted-by":"crossref","first-page":"24580","DOI":"10.1021\/jacs.4c07993","article-title":"Achieving immune activation by suppressing the IDO1 checkpoint with sono-targeted biobromination for antitumor combination immunotherapy","volume":"146","author":"Wen","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"24","key":"10.1016\/j.mtbio.2026.102924_bib21","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.3390\/cancers14246203","article-title":"Natural products\/bioactive compounds as a source of anticancer drugs","volume":"14","author":"Asma","year":"2022","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.mtbio.2026.102924_bib22","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1002\/ptr.8013","article-title":"Galangin: a food\u2010derived flavonoid with therapeutic potential against a wide spectrum of diseases","volume":"37","author":"Wang","year":"2023","journal-title":"Phytother Res."},{"key":"10.1016\/j.mtbio.2026.102924_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.biopha.2017.10.059","article-title":"Galangin (GG) combined with cisplatin (DDP) to suppress human lung cancer by inhibition of STAT3-regulated NF-kappaB and Bcl-2\/Bax signaling pathways","volume":"97","author":"Yu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mtbio.2026.102924_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154877","article-title":"Galangin inhibits programmed cell death-ligand 1 expression by suppressing STAT3 and MYC and enhances T cell tumor-killing activity","volume":"116","author":"Zhong","year":"2023","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.mtbio.2026.102924_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12951-023-01932-0","article-title":"A hybrid nanopharmaceutical for specific-amplifying oxidative stress to initiate a cascade of catalytic therapy for pancreatic cancer","volume":"21","author":"Liu","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.102924_bib26","first-page":"413","article-title":"Smart nanoparticles for cancer therapy","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"18","key":"10.1016\/j.mtbio.2026.102924_bib27","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3390\/polym16182606","article-title":"Recent applications of PLGA in drug delivery systems","volume":"16","author":"Yang","year":"2024","journal-title":"Polymers"},{"issue":"1","key":"10.1016\/j.mtbio.2026.102924_bib28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12951-024-02744-6","article-title":"Tumor targeting peptide TMTP1 modified antigen capture Nano-vaccine combined with chemotherapy and PD-L1 blockade effectively inhibits growth of ovarian cancer","volume":"22","author":"Zhou","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"8","key":"10.1016\/j.mtbio.2026.102924_bib29","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1080\/21645515.2015.1020265","article-title":"DNA is an efficient booster of dendritic cell-based vaccine","volume":"11","author":"Li","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"issue":"18","key":"10.1016\/j.mtbio.2026.102924_bib30","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.7150\/thno.102318","article-title":"Characterization of dipyridamole as a novel ferroptosis inhibitor and its therapeutic potential in acute respiratory distress syndrome management","volume":"14","author":"Chen","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.mtbio.2026.102924_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1380069","article-title":"Bacillus Calmette-Gu\u00e9rin immunotherapy induces an efficient antitumor response to control murine melanoma depending on MyD88 signaling","volume":"15","author":"Borges","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2026.102924_bib32","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.2147\/IJN.S507315","article-title":"Preparation and characterization of mitochondrial-targeted nitronyl nitroxide loaded PLGA nanoparticles for brain injury induced by hypobaric hypoxia in mice","volume":"20","author":"Da","year":"2025","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.mtbio.2026.102924_bib33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12951-025-03255-8","article-title":"Cascade-recharged macrophage-biomimetic ruthenium-based nanobattery for enhanced photodynamic-induced immunotherapy","volume":"23","author":"Xia","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2026.102924_bib34","article-title":"Immunotherapy and prevention of cancer by nanovaccines loaded with whole\u2010cell components of tumor tissues or cells","volume":"33","author":"Ma","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2026.102924_bib35","article-title":"Biomimetic nanoparticles enabled by Cascade cell membrane coating for direct cross\u2010priming of T cells","volume":"18","author":"Chen","year":"2021","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.mtbio.2026.102924_bib36","first-page":"4","article-title":"Comparing mouse models of ovarian cancer","volume":"53","author":"Le Bras","year":"2024","journal-title":"Lab. Anim."},{"issue":"13","key":"10.1016\/j.mtbio.2026.102924_bib37","article-title":"A natural small molecule mitigates kidney fibrosis by targeting Cdc42\u2010mediated GSK\u20103\u03b2\/\u03b2\u2010catenin signaling","volume":"11","author":"Hu","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"10","key":"10.1016\/j.mtbio.2026.102924_bib38","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1016\/j.apsb.2024.08.004","article-title":"Demethylzeylasteral induces PD-L1 ubiquitin\u2013proteasome degradation and promotes antitumor immunity via targeting USP22","volume":"14","author":"Zhang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2026.102924_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.171377","article-title":"Macrophage AHR-TLR4 cross-talk drives p-STAT3 (Ser727)-mediated mitochondrial oxidative stress and upregulates IDO\/ICAM-1 in the steatohepatitis induced by aflatoxin B1","volume":"923","author":"Zhang","year":"2024","journal-title":"Sci. Total Environ."},{"issue":"9","key":"10.1016\/j.mtbio.2026.102924_bib40","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1177\/0960327121997979","article-title":"Chemopreventive effect of galangin against benzo(a)pyrene-induced stomach tumorigenesis through modulating aryl hydrocarbon receptor in Swiss albino mice","volume":"40","author":"Wang","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"issue":"16","key":"10.1016\/j.mtbio.2026.102924_bib41","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1289\/ehp.6322","article-title":"Flavonoids as aryl hydrocarbon receptor agonists\/antagonists: effects of structure and cell context","volume":"111","author":"Zhang","year":"2003","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.mtbio.2026.102924_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124045","article-title":"Nanoparticle-mediated immunogenic cell death for cancer immunotherapy","volume":"656","author":"Qi","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.mtbio.2026.102924_bib43","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/imr.13301","article-title":"Decoding immunogenic cell death from a dendritic cell perspective","volume":"321","author":"Janssens","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.mtbio.2026.102924_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/3251211","article-title":"Galangin-loaded gold nanoparticles: molecular mechanisms of antiangiogenesis properties in breast cancer","volume":"2023","author":"Qaddoori","year":"2023","journal-title":"Int. J. Breast Cancer"},{"issue":"5","key":"10.1016\/j.mtbio.2026.102924_bib45","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41565-022-01098-0","article-title":"A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy","volume":"17","author":"Liu","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.mtbio.2026.102924_bib46","article-title":"Targeting lymph nodes for enhanced cancer vaccination: from nanotechnology to tissue engineering","volume":"26","author":"Wang","year":"2024","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.mtbio.2026.102924_bib47","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s12951-021-01116-8","article-title":"Intracellular signaling pathway in dendritic cells and antigen transport pathway in vivo mediated by an OVA@DDAB\/PLGA nano-vaccine","volume":"19","author":"Han","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"10","key":"10.1016\/j.mtbio.2026.102924_bib48","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.immuni.2023.08.014","article-title":"Dendritic cells as shepherds of T cell immunity in cancer","volume":"56","author":"Pittet","year":"2023","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.mtbio.2026.102924_bib49","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s12276-023-01028-7","article-title":"Immune regulation through tryptophan metabolism","volume":"55","author":"Seo","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.mtbio.2026.102924_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.678999","article-title":"IDO1 expression in ovarian cancer induces PD-1 in T cells via aryl hydrocarbon receptor activation","volume":"12","author":"Amobi-McCloud","year":"2021","journal-title":"Front. Immunol."},{"issue":"23","key":"10.1016\/j.mtbio.2026.102924_bib51","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.1158\/1078-0432.CCR-21-1392","article-title":"Tumor cell IDO enhances immune suppression and decreases survival independent of tryptophan metabolism in glioblastoma","volume":"27","author":"Zhai","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.mtbio.2026.102924_bib52","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s43018-025-00986-3","article-title":"The tumor microenvironment's role in the response to immune checkpoint blockade","volume":"6","author":"Aliazis","year":"2025","journal-title":"Nat. Cancer"},{"issue":"5","key":"10.1016\/j.mtbio.2026.102924_bib53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.mtbio.2026.102924_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.868695","article-title":"The evasion mechanisms of cancer immunity and drug intervention in the tumor microenvironment","volume":"13","author":"Kim","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"33","key":"10.1016\/j.mtbio.2026.102924_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202402199","article-title":"Dendritic cell\u2010hitchhiking in vivo for vaccine delivery to lymph nodes","volume":"11","author":"Zhou","year":"2024","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.mtbio.2026.102924_bib56","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41467-023-35948-9","article-title":"IFN\u03b3 signaling in cytotoxic T cells restricts anti-tumor responses by inhibiting the maintenance and diversity of intra-tumoral stem-like T cells","volume":"14","author":"Mazet","year":"2023","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.mtbio.2026.102924_bib57","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1073\/pnas.0611533104","article-title":"Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer","volume":"104","author":"Hamanishi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.mtbio.2026.102924_bib58","first-page":"633","article-title":"Nano-pulse treatment overcomes the immunosuppressive tumor microenvironment to elicit in situ vaccination protection against","volume":"12","author":"Nanajian","year":"2024","journal-title":"Breast Cancer, Vaccines"},{"issue":"5","key":"10.1016\/j.mtbio.2026.102924_bib59","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ccell.2022.03.008","article-title":"Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells","volume":"40","author":"Anadon","year":"2022","journal-title":"Cancer Cell"}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426001675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426001675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:44:12Z","timestamp":1777635852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426001675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":59,"alternative-id":["S2590006426001675"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.102924","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Galangin-loaded biomimetic dendritic cells membrane nanovaccine reprograms the ovarian cancer microenvironment via Stat3\/IDO1\/AhR axis to boost immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.102924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102924"}}